
Conaris T200 - Dosage Form: Tablet
Price: 141.75 INR / Piece
(135.00 INR + 5% GST)
Get Latest Price
MRP:
141.75 INR / Piece
Weight :
10.00 Gram
1 Pack Contains :
10
Minimum Pack Size :
10
In Stock
Product Specifications
| Indication | Chronic and recurrent fungal infections |
| Pacakaging (Quantity Per Box) | 10 x 1 x 10 Tablets |
| Dosage Form | Tablet |
| Salt Composition | Terbinafine 250 mg + Itraconazole 200 mg |
| Origin of Medicine | India |
| Drug Type | General Medicines |
| Ingredients | Fungal infections of the skin, hair, and nails are becoming increasingly common in India due to humid climate conditions, poor hygiene, diabetes, and recurrent exposure to infections. Treating stubborn or resistant fungal infections often requires a strong and well-balanced antifungal therapy. CONARIS T200, a powerful combination of Terbinafine 250 mg and Itraconazole 200 mg, is specially formulated to provide broad-spectrum antifungal action with faster and more effective results.This dual antifungal combination works by targeting fungal cells at different stages of their growth cycle, ensuring complete eradication of infection while reducing the risk of recurrence. When prescribed under medical supervision, CONARIS T200 plays a crucial role in restoring healthy skin and nail integrity, improving patient comfort, and enhancing overall quality of life.UsesCONARIS T200 is primarily used for the treatment of moderate to severe fungal infections, including:Dermatophytosis (ringworm infections)Tinea corporis (body ringworm)Tinea cruris (jock itch)Tinea pedis (athletes foot)Onychomycosis (fungal nail infections)Recurrent and treatment-resistant fungal infectionsExtensive fungal infections affecting large skin areasThis combination is particularly beneficial in patients who do not respond adequately to single antifungal therapy.BenefitsDual Mechanism of Action: Terbinafine and Itraconazole work together to inhibit fungal growth and destroy fungal cell membranes.Faster Clinical Relief: Helps reduce itching, redness, scaling, and discomfort more quickly.Broad-Spectrum Coverage: Effective against a wide range of dermatophytes, yeasts, and molds.Reduced Recurrence Rate: Ensures complete fungal clearance, lowering the chances of reinfection.Improves Skin and Nail Health: Promotes healing and restoration of normal skin and nail appearance.Convenient Oral Therapy: Easy-to-administer tablet form improves treatment compliance.DosageThe dosage of CONARIS T200 should always be taken as prescribed by a healthcare professional. The dose and duration depend on:Severity and type of fungal infectionSite of infection (skin, scalp, or nails)Patients age, weight, and medical conditionTablets are usually taken orally after meals with water. It is essential to complete the full course of treatment even if symptoms improve earlier, as stopping the medication prematurely may lead to recurrence or resistance.Side EffectsLike all medicines, CONARIS T200 may cause some side effects, though not everyone experiences them. Commonly reported side effects include:Nausea or vomitingAbdominal painHeadacheDiarrheaMild skin rashRare but serious side effects may include liver function abnormalities, taste disturbances, or allergic reactions. Patients should immediately consult a doctor if they notice symptoms such as persistent nausea, dark urine, yellowing of eyes or skin, or severe skin reactions.Precautions and WarningCONARIS T200 should be used only under medical supervision.Patients with liver disease, heart conditions, or kidney impairment should inform their doctor before starting treatment.Regular monitoring of liver function may be required during prolonged therapy.Avoid alcohol consumption while taking this medication, as it may increase the risk of liver-related side effects.Not recommended during pregnancy and breastfeeding unless clearly advised by a healthcare professional.Inform your doctor about all other medications being taken to avoid potential drug interactions.ConclusionCONARIS T200 is a highly effective antifungal combination designed to manage stubborn, recurrent, and resistant fungal infections. With the combined strength of Terbinafine 250 mg and Itraconazole 200 mg, it delivers comprehensive antifungal coverage, faster symptom relief, and long-lasting results. When used responsibly under proper medical guidance, CONARIS T200 helps patients regain healthy skin and nails, prevents recurrence, and significantly improves overall comfort and confidence.For optimal results, always follow your doctors advice and complete the prescribed course of therapy. |
| Physical Form | Tablets |
| Function | Other |
| Recommended For | Management of moderate to severe fungal infections, including resistant and recurrent dermatophytosis and nail fungal infections |
| Dosage | As directed by the physician |
| Dosage Guidelines | Take orally after meals with water. Do not crush or chew the tablet. Complete the full course as prescribed by the doctor. |
| Suitable For | Adults |
| Quantity | As per packaging Strip |
| Storage Instructions | Store in a cool, dry place below 25 C. Protect from moisture and direct sunlight. Keep out of reach of children. |
| Delivery Time | 4 Days |
| MRP | 141.75 INR |
| Unit Type | Piece/Pieces |
| Pkg Box Breadth | 10.00 cm |
| Packsize | 10 |
| GSTIN | 5% |
| Weight | 10.00 Gram |
| Stock Quantity | 5000 |
| Brand Name | CONARIS T200 |
| Price Type | fixed |
| Price | 135.00 INR (Approx.) |
| Pkg Box Length | 10.00 cm |
| Returnable | No |
| Shipping Type | free |
| Currency | INR |
| Mop | 10 |
| Pkg Box Height | 10.00 cm |
| Minimum Ordered Packs | 10 |
Company Details
We are proud to introduce Steris Healthcare Pvt. Ltd., a specialty pharmaceutical company established in May 2018 by a team of highly experienced and proficient pharmaceutical professionals. Since its inception, Steris Healthcare has been dedicated to delivering a wide range of high-quality and affordable pharmaceutical products across multiple super-specialty segments to the global healthcare industry. Steris Healthcare Pvt. Ltd. is a WHO, GMP, and ISO 9001:2018 certified pharma marketing company, accredited by UKAS Management Systems, London, United Kingdom.
Business Type
Supplier, Trading Company
Employee Count
100
Establishment
2018
Working Days
To
GST NO
08ABACS2887B1ZD
Related Products
Explore Related Categories
More Products From This Seller
Seller Details
GST - 08ABACS2887B1ZD
Jaipur, Rajasthan
Business Manager
Ms. Divya Sharma
Members since
4 Years
Address
A68-69, Sunder Singh Bhandari Nagar, Swej Farm Circle, Ram Nagar Ext Sodala, Jaipur, Rajasthan, 302019, India
pharmaceutical medicines in Jaipur
Report incorrect details




























